Approval · Notice of Compliance 20933 · 2018
TEVA-CEFADROXIL: Notice of Compliance 20933
Issued June 4, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20933
- Date
- June 4, 2018
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site for the active pharmaceutical substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-CEFADROXIL | Not yet assigned | — |
Medicinal ingredients
- CEFADROXIL MONOHYDRATE 500 MG per CAP